300+ total transactions representing $5B+ in aggregate value — 10 tracked below spanning 2010–2024 · 6 industries
Growth capital transaction involving SSI Strategy receiving investment from Amulet Capital Partners. Advised on recapitalization to accelerate growth.
Inverness Advisors acted as financial advisor to Corgenix in connection with its acquisition by Orgentec, creating a leading global specialty diagnostics company. Corgenix specializes in immunological and molecular diagnostics.
Inverness Advisors acted as exclusive placement agent for Aviir in securing third $10 million financing tranche. Aviir developed new heart risk test technology.
Inverness Advisors advised Nexus Dx (International Technidyne Corporation) in its acquisition by Warburg Pincus. Diagnostic company transaction expanding Warburg's healthcare portfolio.
Exclusive sell-side advisor to IDEA Pharma, a London-based global consultancy specializing in pharmaceutical path-to-market strategy and innovation. IDEA acquired by SAI MedPartners (Northlane Capital platform). Transaction strengthened SAI's capacity to deliver comprehensive strategic services to biopharma clients from drug discovery through market launch and lifecycle management.
Advisory on the sale of eCommerce Industries to growth equity firm Insight Venture Partners. Eci^2 provides software solutions for digital commerce and ecommerce optimization.